Home › Funds › PFM Health Sciences, LP › RYTM

PFM Health Sciences, LP position in RYTM

RHYTHM PHARMACEUTICALS INC · Health Care

PFM Health Sciences, LP reported holding 101,550 shares of RYTM (RHYTHM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$11.3M, representing 0.99% of its reported portfolio and ranking #38 among its reported holdings. PFM Health Sciences, LP has disclosed RYTM holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)101.55K sh
Reported value held$11.28M
Portfolio Weight0.99%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's RYTM position evolved

PFM Health Sciences, LP first disclosed a stake in RYTM in Q3 2025 at 48,162 shares (US$4.9M). The position peaked in Q1 2026 at 136,621 shares, worth US$11.9M. Across 4 filings, PFM Health Sciences, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 101,550 shares valued at US$11.3M — a reduction of -35,071 shares quarter over quarter.. Notable position changes include a 240% increase in Q1 2026 (shares rose 28% over the following quarter), a 26% trim in Q2 2026 (shares fell 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 48.16K $4.86M New
Q4 2025 40.21K $4.30M Reduce
Q1 2026 136.62K $11.88M Add
Q2 2026 101.55K $11.28M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RYTM and 13F data

RYTM (RHYTHM PHARMACEUTICALS INC) is a Health Care company. 52 other funds we track also report a position in RYTM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$740.2M), BAKER BROS. ADVISORS LP (US$622.3M), PERCEPTIVE ADVISORS LLC (US$287.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RYTM

All RYTM fund holders →

FAQ

How long has PFM Health Sciences, LP held RYTM?

PFM Health Sciences, LP has disclosed RYTM holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is PFM Health Sciences, LP's current position in RYTM?

As of Q2 2026, PFM Health Sciences, LP holds 101.55K shares of RYTM (RHYTHM PHARMACEUTICALS INC), valued at $11.28M, representing 0.99% of its reported portfolio and ranking #38.

Has PFM Health Sciences, LP been buying or selling RYTM?

In the latest 13F filing (Q2 2026), PFM Health Sciences, LP reduced its position in RYTM. The position peaked in Q1 2026 at 136.62K shares.

Which other funds hold RYTM?

Other major institutional holders of RYTM include RA CAPITAL MANAGEMENT, L.P., BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.